Skip to main content
. 2017 Dec 5;15(2):1839–1844. doi: 10.3892/ol.2017.7529

Table III.

Associations between baseline ctDNA concentrations and response to targeted treatment.

BRAFV600E mutation PR SD PD Total P-value
UT   3   6 0   9 0.30
MT 10   7 1 18
Total 13 13 1 27

Qualitative data were statistically analyzed using Mann-Whitney U tests. UT, undetectable type; MT, mutant type; PR, partial responses; SD, stable disease; PD, progressive disease.